Call Us Free: 1-844-612-6621

245 Cancer Cases

The Import permits issued by the Ministry of Health of China for both the “C” formula and “Y” formula to be imported into China as the first ever non-traditional Chinese herbal medicines for cancer was based on this 245 cases of clinical study.  The study was under the strict guidance of the Ministry and conducted by three major hospitals in China.  These hospitals included Beijing Chinese Medicine University East Gate Hospital, People’s Hospital of Gunagdong Province, and Gungzhou City Cancer Hospital.

The original study is being translated into English and will be posted to this site soon.

 

chinese clinical studies

Disclaimer

The information on this website is for educational purpose only. We are not offering any medical advice or guidance to our readers, nor making any attempt to prescribe any medical treatment.

CESSIAC and YUCCALIVE are registered trade-marks of MPS International Marketing Inc. in Canada and the United States. ESSIAC is a registered trade-mark of Essiac Products Inc. in Canada and elsewhere. CESSIAC products are not connected, associated or affiliated in any way with ESSIAC products.